PAS 83 from BSI is designed to raise awareness of relevant UK laws and standards across the stem cell community and to promote best practice across both academic and commercial stakeholder groups
PAS 83 - Stem cell research guidance is available for review.
The British Standards Institution's (BSI) Publicly Available Specification (PAS) to map and inform industry and researchers of the critical path requirements for the development of stem cell therapeutics is now available for review before purchase.
PAS 83 - Guidance on standards, standardized methods and regulation for cell-based therapeutics, from basic research to clinical application was commissioned by the Department of Trade and Industry (DTI) and produced in collaboration with key stakeholders across the UK including stem cell researchers, the biotech industry and regulators.
The PAS explains which laws need to be adhered to and highlights important guidance and standards pertinent to each stage of the research and development process.
It is intended that this PAS will act as a quick reference source on the requirements for exploitation of a cell-based therapy in the UK.
Sample pages can now be downloaded from the BSI website.
The UK government aims to make the UK a global leader in stem cell science and to enable its application to the commercial development of new therapeutics to treat a variety of diseases.
By making PAS 83 widely available via the BSI website it is hoped that this will increase reassurance among the general public that the complex ethical issues surrounding cell-based therapy research are under strict regulation.
PAS 83 is available to purchase at BSI's online store.
